药用明胶市场－全球产业规模、份额、趋势、机会和预测，按类型、来源、功能、最终用户、地区和竞争细分，2020-2030 年

2024 年全球药用明胶市场价值为 18.9 亿美元，预计到 2030 年将达到 26.1 亿美元，复合年增长率为 5.51%。药用明胶是一种重要的赋形剂，因其生物相容性且能够满足严格的安全性和纯度标准，广泛用于胶囊、药片和止血剂等药物製剂中。药用明胶主要来自动物胶原蛋白，经过严格的加工，包括灭菌和净化，以确保其不含病原体、过敏原和有害物质。它在增强药物稳定性、生物利用度和患者依从性方面的一致表现使其成为各种治疗应用中不可或缺的一部分。地区偏好和监管指南通常决定明胶的来源—无论是牛、猪、鱼或家禽。口服剂型的需求不断成长，加上製药製造技术的进步，持续推动全球市场扩张。

关键市场驱动因素

製药业蓬勃发展

主要市场挑战

原物料供应和价格波动

主要市场趋势

转向植物性替代品

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球药用明胶市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（A型、B型）
  • 依来源（猪、牛皮、牛骨、鱼、家禽）
  • 依功能（稳定、增稠、胶凝、其他）
  • 按最终用户（硬胶囊、软胶囊、片剂、可吸收止血剂、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美药用明胶市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲药用明胶市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太药用明胶市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲药用明胶市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲药用明胶市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Gelita AG
• Trobas Pharmaceutical gelatine BV
• Rousselot SAS
• Gelatines Weishardt SAS
• Sterling Biotec Ltd.
• Catalent, Inc
• Nitta Pharmaceutical Gelatin India Limited
• Aspire Pharmaceuticals
• Gelco International
• Lapi Gelatine Spa

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Pharmaceutical Gelatin Market was valued at USD 1.89 billion in 2024 and is projected to reach USD 2.61 billion by 2030, registering a CAGR of 5.51%. Pharmaceutical gelatin is a critical excipient widely used in drug formulations such as capsules, tablets, and hemostats due to its biocompatibility and ability to meet stringent safety and purity standards. Derived primarily from animal collagen, pharmaceutical gelatin undergoes rigorous processing, including sterilization and purification, to ensure it is free from pathogens, allergens, and harmful substances. Its consistent performance in enhancing drug stability, bioavailability, and patient compliance makes it indispensable across various therapeutic applications. Regional preferences and regulatory guidelines often dictate the source of gelatin-whether bovine, porcine, fish, or poultry. The growing demand for oral dosage forms, coupled with technological advances in pharmaceutical manufacturing, continues to propel market expansion globally.

Key Market Drivers

Growing Pharmaceutical Industry

The expanding pharmaceutical sector is a primary driver of the pharmaceutical gelatin market, with increasing demand for effective and patient-friendly dosage forms such as capsules. Gelatin plays a vital role in improving drug solubility, enabling controlled drug release, and enhancing the overall stability of active pharmaceutical ingredients (APIs). Regulatory bodies like the FDA and EMA recognize gelatin as a safe and effective excipient when manufactured under strict quality controls and Good Manufacturing Practices (GMP). This endorsement strengthens its widespread use in both conventional and advanced drug delivery systems. As pharmaceutical innovation continues to grow, particularly in personalized medicine and complex therapies, gelatin's functional versatility is expected to further solidify its market position.

Key Market Challenges

Raw Material Supply and Price Volatility

The pharmaceutical gelatin market faces notable challenges due to the reliance on animal-derived raw materials such as bovine and porcine collagen. Factors like disease outbreaks (e.g., African swine fever), climate events, and fluctuating livestock populations can disrupt supply chains and elevate production costs. Environmental concerns, ethical considerations, and rising interest in alternative materials also add complexity to sourcing decisions. Additionally, raw material costs are sensitive to variables such as feed prices, transportation, and currency fluctuations, leading to inconsistent pricing. Meeting stringent regulatory requirements for pharmaceutical-grade gelatin adds further layers of cost and operational effort. These dynamics collectively pose risks to production stability and profitability, particularly for manufacturers operating in price-sensitive markets.

Key Market Trends

Shift Towards Plant-Based Alternatives

The rising demand for sustainable, cruelty-free, and allergen-friendly products is driving interest in plant-based alternatives to animal-derived pharmaceutical gelatin. These alternatives cater to growing vegan and vegetarian populations and meet religious or cultural dietary restrictions. They also present a more environmentally sustainable option, often requiring fewer natural resources and generating lower greenhouse gas emissions. Recent advancements in food and material science have enabled the development of plant-based gelling agents that mimic the functional properties of traditional gelatin. As pharmaceutical companies seek to diversify their excipient sources, plant-based gelatin substitutes are gaining attention for their potential to meet both functional and ethical criteria. However, achieving comparable performance and regulatory approval remains a focus of ongoing innovation.

Key Market Players

• Gelita AG
• Trobas Pharmaceutical gelatine B.V
• Rousselot SAS
• Gelatines Weishardt SAS
• Sterling Biotec Ltd.
• Catalent, Inc
• Nitta Pharmaceutical Gelatin India Limited
• Aspire Pharmaceuticals
• Gelco International
• Lapi Gelatine S.p.a

Report Scope:

In this report, the Global Pharmaceutical Gelatin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Gelatin Market, By Type:

• Type A
• Type B

Pharmaceutical Gelatin Market, By Source:

• Porcine
• Bovine Skin
• Bovine Bone
• Fish
• Poultry

Pharmaceutical Gelatin Market, By Function:

• Stabilizing
• Thickening
• Gelling
• Others

Pharmaceutical Gelatin Market, By End User:

• Hard Capsule
• Soft Capsule
• Tablet
• Absorbable Hemostat
• Others

Pharmaceutical Gelatin Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pharmaceutical Gelatin Market.

Available Customizations:

Global Pharmaceutical Gelatin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Pharmaceutical Gelatin Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Type A, Type B)
  • 5.2.2. By Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry)
  • 5.2.3. By Function (Stabilizing, Thickening, Gelling, Others)
  • 5.2.4. By End User (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Pharmaceutical Gelatin Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Source
  • 6.2.3. By Function
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmaceutical Gelatin Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Source
      • 6.3.1.2.3. By Function
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Pharmaceutical Gelatin Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Source
      • 6.3.2.2.3. By Function
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Pharmaceutical Gelatin Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Source
      • 6.3.3.2.3. By Function
      • 6.3.3.2.4. By End User

7. Europe Pharmaceutical Gelatin Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Source
  • 7.2.3. By Function
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pharmaceutical Gelatin Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Source
      • 7.3.1.2.3. By Function
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Pharmaceutical Gelatin Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Source
      • 7.3.2.2.3. By Function
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Pharmaceutical Gelatin Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Source
      • 7.3.3.2.3. By Function
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Pharmaceutical Gelatin Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Source
      • 7.3.4.2.3. By Function
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Pharmaceutical Gelatin Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Source
      • 7.3.5.2.3. By Function
      • 7.3.5.2.4. By End User

8. Asia-Pacific Pharmaceutical Gelatin Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Source
  • 8.2.3. By Function
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pharmaceutical Gelatin Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Source
      • 8.3.1.2.3. By Function
      • 8.3.1.2.4. By End User
  • 8.3.2. India Pharmaceutical Gelatin Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Source
      • 8.3.2.2.3. By Function
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Pharmaceutical Gelatin Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Source
      • 8.3.3.2.3. By Function
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Pharmaceutical Gelatin Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Source
      • 8.3.4.2.3. By Function
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Pharmaceutical Gelatin Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Source
      • 8.3.5.2.3. By Function
      • 8.3.5.2.4. By End User

9. South America Pharmaceutical Gelatin Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Source
  • 9.2.3. By Function
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Gelatin Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Source
      • 9.3.1.2.3. By Function
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Pharmaceutical Gelatin Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Source
      • 9.3.2.2.3. By Function
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Pharmaceutical Gelatin Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Source
      • 9.3.3.2.3. By Function
      • 9.3.3.2.4. By End User

10. Middle East and Africa Pharmaceutical Gelatin Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Source
  • 10.2.3. By Function
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Gelatin Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Source
      • 10.3.1.2.3. By Function
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Pharmaceutical Gelatin Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Source
      • 10.3.2.2.3. By Function
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Pharmaceutical Gelatin Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Source
      • 10.3.3.2.3. By Function
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Gelita AG
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Trobas Pharmaceutical gelatine B.V
• 14.3. Rousselot SAS
• 14.4. Gelatines Weishardt SAS
• 14.5. Sterling Biotec Ltd.
• 14.6. Catalent, Inc
• 14.7. Nitta Pharmaceutical Gelatin India Limited
• 14.8. Aspire Pharmaceuticals
• 14.9. Gelco International
• 14.10. Lapi Gelatine S.p.a

15. Strategic Recommendations

16. About Us & Disclaimer